The Optos team constantly strives to improve upon our retinal imaging technology. In our effort to be THE retina company, we realize our technology is not only saving vision, it is also saving lives.
Denise Kniefel, OD knows the value of the optomap® exam because she has been a customer of Optos since 2004. No stranger to the technology, Dr. Kniefel started imaging her retina as a matter of course. In 2008 at a tradeshow, she stopped in to talk to the representatives from the company. Optos had recently unveiled new technology that allowed for even better optomap imaging than in the past. Dr. Kniefel sat down and had her retinal image captured. A nevus was detected that she hadn’t previously seen.
The image prompted Dr. Kniefel to see her ophthalmologist and have a fluorescein angiography and an OCT exam done. She did indeed have a nevus, which is essentially a freckle in the eye, and needs to be routinely monitored. Just like a freckle on your skin, it can change and become cancerous. Her doctor told her if the nevus did change into cancerous melanoma of eye, she would notice changes to her vision.
